Authors:
CLIFFORD SL
KAMINETSKY CP
CIRISANO FD
DODGE R
SOPER JT
CLARKEPEARSON DL
BERCHUCK A
Citation: Sl. Clifford et al., RACIAL DISPARITY IN OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN STAGE-I ENDOMETRIAL CANCER, American journal of obstetrics and gynecology, 176(6), 1997, pp. 229-232
Authors:
ELBENDARY AA
CIRISANO FD
EVANS AC
DAVIS PL
IGLEHART JD
MARKS JR
BERCHUCK A
Citation: Aa. Elbendary et al., RELATIONSHIP BETWEEN P21 EXPRESSION AND MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IN NORMAL AND MALIGNANT OVARIAN EPITHELIAL-CELLS, Clinical cancer research, 2(9), 1996, pp. 1571-1575
Citation: Fd. Cirisano et By. Karlan, THE ROLE OF THE HER-2 NEU ONCOGENE IN GYNECOLOGIC CANCERS/, Journal of the Society for Gynecologic Investigation, 3(3), 1996, pp. 99-105
Authors:
CASEY AC
FARIASEISNER R
PISANI AL
CIRISANO FD
KIM YB
MUDERSPACH L
FUTORAN R
LEUCHTER RS
LAGASSE LD
KARLAN BY
Citation: Ac. Casey et al., WHAT IS THE ROLE OF REASSESSMENT LAPAROSCOPY IN THE MANAGEMENT OF GYNECOLOGIC CANCERS IN 1995, Gynecologic oncology, 60(3), 1996, pp. 454-461
Citation: Fd. Cirisano et al., APPARENT HEPARIN RESISTANCE FROM ELEVATED FACTOR-VIII IN A PATIENT WITH POSTOPERATIVE DEEP VENOUS THROMBOSIS - A CASE-REPORT, Journal of reproductive medicine, 41(3), 1996, pp. 191-194
Authors:
FARIASEISNER R
CIRISANO FD
GROUSE D
LEUCHTER RS
KARLAN BY
LAGASSE LD
BEREK JS
Citation: R. Fariaseisner et al., CONSERVATIVE AND INDIVIDUALIZED SURGERY FOR EARLY SQUAMOUS CARCINOMA OF THE VULVA - THE TREATMENT OF CHOICE FOR STAGE-I AND II (T1-2N0-1M0)DISEASE, Gynecologic oncology, 53(1), 1994, pp. 55-58
Authors:
CIRISANO FD
GREENSPOON JS
STENSON R
FARIASEISNER R
KARLAN BY
LAGASSE LD
Citation: Fd. Cirisano et al., THE ETIOLOGY AND MANAGEMENT OF DIARRHEA IN THE GYNECOLOGIC ONCOLOGY PATIENT, Gynecologic oncology, 50(1), 1993, pp. 45-48